Skip to main content

Security report for megafyt-pharma.cz

Megafyt Pharma s.r.o. · Healthcare · Czech Republic

High risk. 10 critical or high findings in GDPR outside view, Email security and 2 other checks.

Security score

47/100

Risk levelHigh

0–100, higher is better. How it is calculated

Megafyt Pharma s.r.o. is a Czech-based company specializing in the production and sale of high-quality herbal teas, phytopharmaceuticals, and related products primarily distributed through pharmacies. The website targets consumers interested in natural health products, offering a comprehensive catalog including medicinal teas, children's teas, wellbeing products, and limited edition collections. The company maintains a consistent brand presence with clear contact information and active social media channels, positioning itself as a trusted player in the Czech and Slovak herbal healthcare market. Technically, the website employs a custom or proprietary CMS platform with JavaScript and jQuery libraries, integrates Google Analytics for visitor tracking, and uses Google reCAPTCHA for form security. The site is mobile-optimized with good navigation and SEO practices, although some accessibility features are basic. Cookie consent is implemented with a granular mechanism, supporting GDPR compliance to some extent. From a security perspective, the site uses HTTPS and has implemented cookie consent and reCAPTCHA, but lacks visible security headers such as CSP or HSTS. No critical vulnerabilities or exposed sensitive data were detected. However, the absence of a privacy policy and terms of service pages, along with missing WHOIS registration data, reduces overall trustworthiness and compliance posture. Overall, the website is professional and trustworthy in content and business presentation but would benefit from enhanced security headers, explicit privacy and legal policies, and resolution of WHOIS data issues to improve domain legitimacy and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
25/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

10 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  3. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection
  4. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

Need hands-on remediation? Email guard@offseq.com

Keep watching megafyt-pharma.cz

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
95
Security headers
25
Email security
60
DNS health
75
Network security
0
GDPR outside view
25
Average
47

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Megafyt Pharma operates in the healthcare sector focusing on herbal and phytopharmaceutical products. Its market positioning leverages pharmaceutical quality claims and distribution through pharmacies, targeting health-conscious consumers in Czech Republic and Slovakia. The business model is retail and wholesale of herbal teas and related products. The company shows moderate digital maturity with active social media engagement and basic marketing analytics. Revenue streams likely come from product sales and limited edition collections. The partnership ecosystem includes digital service providers like Digimadi.cz for website management. Growth indicators are not explicit but product diversity and new product launches suggest ongoing development. Strategic observations include the need to improve digital trust signals and compliance documentation to support market expansion and regulatory adherence.

Security posture

The website demonstrates a moderate security maturity level with HTTPS enforced and use of Google reCAPTCHA to protect forms. Cookie consent management is implemented with user choice, supporting privacy compliance. However, the lack of security headers such as Content Security Policy, HSTS, and X-Frame-Options reduces defense-in-depth. No incident response or security policy information is publicly available, indicating limited transparency in security governance. No vulnerabilities or malware were detected in the analysis. Compliance gaps include missing explicit privacy policy and terms of service pages, which are critical for GDPR and other regulations. Overall, the security posture is adequate for a retail website but requires improvements in headers, documentation, and incident response readiness to enhance resilience and trust.

Recommendations

  1. Implement comprehensive privacy policy and terms of service pages clearly accessible from the website footer or main menu.
  2. Add and configure security headers including Content Security Policy (CSP), HTTP Strict Transport Security (HSTS), X-Frame-Options, and X-XSS-Protection.
  3. Resolve WHOIS data availability issues to improve domain registration transparency and trustworthiness.
  4. Establish and publish incident response contact information and security policy to demonstrate security governance.
  5. Regularly audit third-party scripts and dependencies to mitigate potential vulnerabilities and ensure compliance with privacy regulations.

Contact details published on the site

Addresses
Legal name
Megafyt Pharma s.r.o.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Megafyt Pharma s.r.o.
Description
Ucelená nabídka bylinných čajů, bylinných preparátů a fytofarmak nejvyšší kvality – dostupných pouze v lékárnách
Key services
Production and sale of medicinal herbal teas, Bylinková lékárna (herbal pharmacy products), Children's teas, Fruit and other teas, Wellbeing products, Limited edition tea collections
Content quality
good
Branding
consistent

Technology

Stack
JavaScript, jQuery, Google Analytics, Custom cookie consent script
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner with granular consent options
  • Google reCAPTCHA integration on forms

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
basic

Advertising

Marketing tools
Cookie consent management
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in Czech language
  2. No WHOIS data available, which is unusual and reduces domain trust
  3. Cookie consent mechanism is implemented with granular options
  4. No explicit privacy policy or terms of service pages found
  5. Contact information is clearly presented with physical address, phone, and email
  6. Social media presence on Facebook and Instagram
  7. Use of Google Analytics and reCAPTCHA for analytics and spam prevention
  8. No security headers detected in provided data
  9. No signs of malware or phishing
  10. No adult or questionable content detected
Technical notes

Notes

The website is built on a custom or proprietary CMS platform (likely Get-Webseller) using JavaScript and jQuery libraries. It integrates Google Analytics for visitor tracking and Google reCAPTCHA for spam prevention on forms. The site is mobile-optimized with responsive design and good SEO meta tags. Performance is moderate with multiple external script loads. Accessibility features are basic but present. The cookie consent mechanism is well implemented with granular user controls. However, the absence of security headers and incomplete WHOIS data represent technical risks. Hosting provider details are not disclosed. Overall, the technical infrastructure supports business needs but requires modernization in security and compliance aspects to reduce technical debt and improve operational security.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with megafyt-pharma.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review megafyt-pharma.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.